Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,701 to 1,720 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LncARSR sponges miR-129-5p to promote proliferation and metastasis of bladder cancer cells through increasing SOX4 expression. | Int J Biol Sci | 2020 | 31892841 | PubTator, text mining | PubMed |
| Circular RNAs and gastrointestinal cancers: Epigenetic regulators with a prognostic and therapeutic role. | Crit Rev Oncol Hematol | 2020 | 31877535 | PubTator, text mining | PubMed |
| lncRNA THAP9-AS1 Promotes Pancreatic Ductal Adenocarcinoma Growth and Leads to a Poor Clinical Outcome via Sponging miR-484 and Interacting with YAP. | Clin Cancer Res | 2020 | 31831555 | PubTator, text mining | PubMed |
| Abnormal increase of miR-4262 promotes cell proliferation and migration by targeting large tumor suppressor 1 in gliomas. | Pathol Res Pract | 2020 | 31831299 | PubTator, text mining | PubMed |
| Hippo-Yap/Taz signaling: Complex network interactions and impact in epithelial cell behavior. | Wiley Interdiscip Rev Dev Biol | 2020 | 31828974 | PubTator, text mining | PubMed |
| LncRNA SNHG15: A new budding star in human cancers. | Cell Prolif | 2020 | 31774607 | PubTator, text mining | PubMed |
| Inhibition of cyclin-dependent kinase 7 down-regulates yes-associated protein expression in mesothelioma cells. | J Cell Mol Med | 2020 | 31755214 | PubTator, text mining | PubMed |
| Lactate-fueled oxidative metabolism drives DNA methyltransferase 1-mediated transcriptional co-activator with PDZ binding domain protein activation. | Cancer Sci | 2020 | 31746077 | PubTator, text mining | PubMed |
| The YAP1 Signaling Inhibitors, Verteporfin and CA3, Suppress the Mesothelioma Cancer Stem Cell Phenotype. | Mol Cancer Res | 2020 | 31732616 | PubTator, text mining | PubMed |
| The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa. | Cell Mol Gastroenterol Hepatol | 2020 | 31669263 | PubTator, text mining | PubMed |
| Long non-coding RNA TNRC6C-AS1 promotes methylation of STK4 to inhibit thyroid carcinoma cell apoptosis and autophagy via Hippo signalling pathway. | J Cell Mol Med | 2020 | 31657132 | PubTator, text mining | PubMed |
| Upstream regulation of the Hippo-Yap pathway in cardiomyocyte regeneration. | Semin Cell Dev Biol | 2020 | 31606277 | PubTator, text mining | PubMed |
| PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1. | Oncogene | 2020 | 31605013 | PubTator, text mining | PubMed |
| Integrative Exome Sequencing Analysis in Castration-Resistant Prostate Cancer in Chinese Population. | Curr Pharm Biotechnol | 2020 | 31580249 | PubTator, text mining | PubMed |
| CHI3L1 promotes proliferation and improves sensitivity to cetuximab in colon cancer cells by down-regulating p53. | J Clin Lab Anal | 2020 | 31536166 | PubTator, text mining | PubMed |
| Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome. | Cell Biol Toxicol | 2020 | 31485828 | PubTator, text mining | PubMed |
| Exploring the long noncoding RNAs-based biomarkers and pathogenesis of malignant transformation from dysplasia to oral squamous cell carcinoma by bioinformatics method. | Eur J Cancer Prev | 2020 | 31343435 | PubTator, text mining | PubMed |
| VprBP mitigates TGF-β and Activin signaling by promoting Smurf1-mediated type I receptor degradation. | J Mol Cell Biol | 2020 | 31291647 | PubTator, text mining | PubMed |
| Mu-KRAS attenuates Hippo signaling pathway through PKCι to sustain the growth of pancreatic cancer. | J Cell Physiol | 2020 | 31230347 | PubTator, text mining | PubMed |
| Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified. | Mod Pathol | 2020 | 31028364 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=86